Jobs
View more job listings or post a job
Genentech Senior/Principal Scientific Researcher (Cell-based Assay Development), BioAnalytical Sciences Department, Genentech
University of California, Davis PHARMACOLOGY TECHNICIAN (SRA 2, NEX)
Vir Biotechnology Director, Regulatory Affairs
Vir Biotechnology Senior Director, Business Development
Vir Biotechnology Senior Scientist, Host Directed Therapy, Click here to apply
PTC Therapeutics Director, Clinical Pharmacology
Alturas Analytics Quality Assurance Director
MCure Biosciences Scientist or Research Associate
Cytokinetics Director/Senior Director, DMPK
Inotiv Senior Toxicologist / Study Director
Post a job

Symposium

[Free Online Seminar] Fighting pancreatic cancer: current treatments, pipeline landscape, and PanCAN's drug development projects


Speakers: Anne-Marie Duliege, MD, Chief Medical Officer, Pancreatic Cancer Network (PanCAN)
Organizers:
Date: 2021-12-07- 12/5/2021
Time: 11:30-13:30 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-12-06  (it will close sooner if the seating cap is reached)

About the Topic

Drug development in metastatic pancreatic ductal adenocarcinoma (PDAC) has been disappointing with a 5 year survival rate of only 10% despite considerable effort.  Precision Promise is a transformative, adaptive registration clinical trial platform that attempts to correct this by continuously and rapidly evaluating novel therapeutic options while nurturing enhanced cooperation among groups representing patient advocacy, pharmaceuticals, translational/clinical academia, and the FDA. This patient-centric study represents a fundamental shift that can substantially accelerate drug development for PDAC . PanCAN is also leading translational research by facilitating genetic testing of patients with pancreatic cancer (“Know Your Tumor” program), and has recently launched an Early Detection Initiative (EDI) in patients with recent onset diabetes.


About the Speakers

As Chief Medical Officer for the Pancreatic Cancer Action Network, Anne-Marie Duliege, MD, is responsible for the strategic direction and operational oversight for the organization’s clinical initiatives, including PanCAN’s Precision Promise℠ clinical trial.

From 2004 to 2013, Dr. Duliege was VP then CMO and Head of Research and Clinical Development at Affymax. Under her leadership, her team completed an extensive development program and obtained FDA approval of the company’s lead product for anemia in dialysis patients. Prior to that, Dr. Duliege worked at Chiron and Genentech on various programs including an HIV vaccine and treatment. Prior to her career in the biopharmaceutical industry, Dr. Duliege was an epidemiologist with the National Institute of Science and Medical Research in Paris.


2022-07-27, [Free Online Symposium] Success Stories and Lessons Learned from Recent FDA Approvals: VOXZOGO (vosoritide) by BioMarin Pharmaceutical Inc.
2022-08-17, [Free Online Symposium] Advances in Oncology
2022-09-15, [Free Online workshop] Immunogenicity of Biologic Drugs – Clinical Relevance case studies, Predictive Tools & Challenges with New modalities
2022-11-02, [Free Online workshop] Bispecific Antibodies: Discovery, Engineering, Development and Regulatory Considerations
2022-11-14, [Free Online Symposium] Advances in Cell therapy
©Pharmaceutical & BioScience Society, International; Last Modified: 6/27/2022; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Laviana Pharma Corp Laviana’s new GMP facility will be validated very soon! We’re taking bookings for API, Intermediate & Custom Synthesis and R&D services for Q2-2023
Veloxity Labs, LLC The unique employee-owned LC-MS/MS bioanalytical CRO with >100 years of experience and the responsiveness of a start-up! GLP and non-GLP.
Hypha Discovery Synthesis, purification & NMR characterization of phase 1 and 2 drug metabolites at mg-g scale with COAs. Also experts in natural products.
Submit a Text Ad